Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
作者机构:Azienda Ospedaliero-UniversitariaModenaItaly
出 版 物:《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养(英文))
年 卷 期:2022年第11卷第6期
页 面:886-888页
核心收录:
学科分类:02[经济学] 0202[经济学-应用经济学] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学]
摘 要:Abnormal chemical reactions disrupting physiological bio-transformations in human body set the stage for the development of metabolic disorders(1).Clinically and epidemiologically,the metabolic syndrome is the most demanding among metabolic disorders in as much as it is globally common and exacts a major toll in terms of healthcare expenditures.